| Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival- NOT-AI-22-023 |
R21, R01
|
February 23, 2022 |
May 08, 2026 |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement, Clinical Trial Optional)- PA-20-135 |
Supp
|
March 10, 2020 |
September 08, 2025 |
| Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection- NOT-HL-22-004 |
R01, R21
|
December 21, 2021 |
September 08, 2025 |
| Notice of Special Interest (NOSI)— Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) - NOT-AI-22-042 |
R01
|
April 29, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 |
R01, R41/R42, R21, R43/R44
|
April 29, 2022 |
May 08, 2025 |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 |
R01
|
May 10, 2022 |
May 08, 2025 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 |
R21
|
May 10, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)— Climate Change and Health- NOT-ES-22-006 |
Multiple |
June 01, 2022 |
May 08, 2025 |
| Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)- PAR-22-185 |
X01
|
May 27, 2022 |
January 18, 2025 |
| Limited Competition—Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)- RFA-HL-23-007 |
K38
|
March 14, 2022 |
January 11, 2025 |
| Notice of Special Interest (NOSI)—Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes- NOT-AI-21-080 |
R21, R01
|
October 18, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity- NOT-AI-21-072 |
R21
|
October 20, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Accelerating Progress in Celiac Disease Research- NOT-AI-22-004 |
Multiple |
November 23, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity- NOT-AI-21-082 |
R01, R21
|
November 29, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery- NOT-AI-22-014 |
R01
|
December 01, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Universal Influenza Vaccine- NOT-AI-22-013 |
R01, R21
|
December 13, 2021 |
January 08, 2025 |
| Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-22-060 |
R15
|
January 10, 2022 |
January 08, 2025 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)- PAR-22-075 |
K22
|
January 20, 2022 |
January 08, 2025 |
| Transgender People—Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)- PAR-22-186 |
R21
|
May 19, 2022 |
December 08, 2024 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States- NOT-GM-22-005 |
Supp
|
April 06, 2022 |
October 18, 2024 |
| NIAID Research Education Program (R25 Clinical Trial Not Allowed)- PAR-22-134 |
R25
|
March 15, 2022 |
October 10, 2024 |
| Notice of Special Interest (NOSI)—Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)- NOT-AI-21-074 |
Supp
|
September 24, 2021 |
September 24, 2024 |
| Administrative Supplements To Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-21-345 |
Supp
|
September 10, 2021 |
September 10, 2024 |
| Limited Competition—Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)- PAS-21-245 |
R34
|
June 14, 2021 |
September 08, 2024 |
| Notice of Special Interest (NOSI)—Understanding the Immune Functions of DEAD/H-box Helicases- NOT-AI-21-066 |
R21, R01
|
July 22, 2021 |
September 08, 2024 |
